Krystal Biotech Inc Share Price Today: Live Updates & Key Insights

Krystal Biotech Inc share price today is $251.36, up -2.45%. The stock opened at $259 against the previous close of $258, with an intraday high of $261.98 and low of $250.35.

Krystal Biotech Inc Share Price Chart

Krystal Biotech Inc

us-stock
To Invest in {{usstockname}}
us-stock

Krystal Biotech Inc Share Price Performance

$251.36 -0.0245(-2.45%) KRYS at 23 Mar 2026 01:54 PM Biotechnology
Lowest Today 250.35
Highest Today 261.98
Today’s Open 259
Prev. Close 258
52 Week High 298.30
52 Week Low 122.80
Day’s Range: Low 250.35 High 261.98
52-Week Range: Low 122.80 High 298.30
1 day return -
1 Week return +0.8
1 month return -8.42
3 month return +0.88
6 month return +51.96
1 year return +29.24
3 year return +247.65
5 year return +226.02
10 year return -

Krystal Biotech Inc Institutional Holdings

FMR Inc 14.88

BlackRock Inc 13.12

venBio Select Advisor LLC 9.88

Vanguard Group Inc 9.51

Fidelity Select Biotechnology 6.20

iShares Core S&P Small-Cap ETF 5.35

State Street Corp 4.78

Fidelity Growth Compy Commingled Pl S 3.60

Soleus Capital Management, L.P. 3.49

Vanguard Total Stock Mkt Idx Inv 2.82

Capital World Investors 2.77

American Funds SMALLCAP World A 2.57

Fidelity Growth Company Fund 2.57

Redmile Group, LLC 2.26

Hood River Capital Management LLC 2.10

Geode Capital Management, LLC 2.09

iShares Russell 2000 ETF 2.06

Vanguard Small Cap Index 2.02

Dimensional Fund Advisors, Inc. 1.69

Frazier Life Sciences Management, L.P. 1.67

T. Rowe Price Associates, Inc. 1.60

Bellevue Group AG 1.40

State Street® SPDR® S&P® Biotech ETF 1.39

Citadel Advisors Llc 1.32

William Blair Investment Management, LLC 1.29

The Goldman Sachs Group Inc 1.19

Hood River Small-Cap Growth Instl 1.13

Vanguard Small Cap Growth Index Inv 1.12

First Trust NYSE Arca Biotech ETF 1.06

T. Rowe Price Health Sciences 1.00

JPMorgan Chase & Co 1.00

NORGES BANK 0.97

Vanguard Institutional Extnd Mkt Idx Tr 0.95

Northern Trust Corp 0.85

Fidelity Small Cap Index 0.83

State Street SPDR Port S&P 600 Sm CpETF 0.82

Fidelity Growth Company K6 0.77

iShares S&P Small-Cap 600 Growth ETF 0.75

iShares Russell 2000 Growth ETF 0.71

Fidelity Series Growth Company 0.68

Krystal Biotech Inc Market Status

Strong Buy: 8

Buy: 2

Hold: 1

Sell: 0

Strong Sell: 0

Krystal Biotech Inc Fundamentals

Market Cap 7357.16 M

PB Ratio 6.0252

PE Ratio 36.7953

Enterprise Value 6529.64 M

Total Assets 1333.79 M

Volume 839965

Krystal Biotech Inc Company Financials

Annual Revenue FY25:389130000 389.1M, FY24:290515000 290.5M, FY23:50699000 50.7M, FY22:0 0.0M, FY21:0 0.0M

Annual Profit FY25:360357000 360.4M, FY24:270454000 270.5M, FY23:42598000 42.6M, FY22:null 0.0M, FY21:null 0.0M

Annual Net worth FY25:204831000 204.8M, FY24:89159000 89.2M, FY23:10932000 10.9M, FY22:-139975000 -140.0M, FY21:-69570000 -69.6M

Quarterly Revenue Q4/2025:107105000 107.1M, Q3/2025:97800000 97.8M, Q2/2025:96042000 96.0M, Q1/2025:88183000 88.2M, Q4/2024:91139000 91.1M

Quarterly Profit Q4/2025:96188000 96.2M, Q3/2025:92137000 92.1M, Q2/2025:88877000 88.9M, Q1/2025:83155000 83.2M, Q4/2024:86190000 86.2M

Quarterly Net worth Q4/2025:51400000 51.4M, Q3/2025:79365000 79.4M, Q2/2025:38333000 38.3M, Q1/2025:35733000 35.7M, Q4/2024:45479000 45.5M

About Krystal Biotech Inc & investment objective

Company Information Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.

Organisation Biotechnology

Employees 295

Industry Biotechnology

CEO Mr. Krish S. Krishnan M.B.A., M.S.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Krystal Biotech Inc FAQs

What is the share price of Krystal Biotech Inc today?

The current share price of Krystal Biotech Inc is $251.36.

Can I buy Krystal Biotech Inc shares in India?

Yes, Indian investors can buy Krystal Biotech Inc shares by opening an international trading and demat account with Motilal Oswal.

How to buy Krystal Biotech Inc shares in India?

You can easily invest in Krystal Biotech Inc shares from India by:

Can I buy fractional shares of Krystal Biotech Inc?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Krystal Biotech Inc?

Krystal Biotech Inc has a market cap of $7357.16 M.

In which sector does Krystal Biotech Inc belong?

Krystal Biotech Inc operates in the Biotechnology sector.

What documents are required to invest in Krystal Biotech Inc stocks?

To invest, you typically need:

What is the PE and PB ratio of Krystal Biotech Inc?

The PE ratio of Krystal Biotech Inc is 36.80 and the PB ratio is 6.03.